摘要
通过文献研究和对比研究,了解美国、欧盟、日本的监管科学在制度理念、技术和人才培养方面的发展经验和实践成果。美国构建监管科学交流平台、欧盟分机构强化立法监管、日本进行整体监管和行业自律监管,有效地推动了本国药品监管科学的发展。我国应转变药品监管科学发展理念、加强药品监管科学制度化建设、重视监管人才队伍建设、促进药品监管智能化和信息化发展以及积极参与监管科学国际交流与合作,以发展我国药品监管科学。
Through literature research and comparative research, we can understand institutional concept, technology and talent training of the regulatory science in the United States, the European Union and Japan. China should change the concept of scientific development of drug supervision, strengthen the construction of scientific system of drug supervision, attach importance to the construction of supervision talents, promote the development of intelligent and information technology of drug supervision, and actively participate in the international exchange and cooperation of supervision science in order to develop the science of drug supervision in China.
作者
王芷薇
Wang Zhi-Wei(China Pharmaceutical University,Nanjing 211198,China)
出处
《中国药物经济学》
2020年第6期24-30,共7页
China Journal of Pharmaceutical Economics
关键词
监管科学
药品安全监管
医药行业发展
Regulatory science
Drug safety supervision
Pharmaceutical industry development
